What does preclinical development of a monoclonal antibody really involve? It’s a balance between process excellence and scientific validation.
In this video, Valentina Fiori, Biologics R&D Manager at Diatheva, explains the two key pillars of preclinical antibody development: from production process development to the gathering of functionality and toxicity data needed to assess the molecule’s potential.
A structured approach that combines manufacturing expertise with rigorous scientific evaluation.
